One of the best Hades-style roguelikes I've played, Lost in Random: The Eternal Die offers unique mechanics and doesn't outstay its welcome.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

This strategy can boost yield while reducing portfolio risk. Investors can still find decent returns from GICs and TSX dividend stocks. GIC rates are still comfortably above the rate of inflation on ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

More than 100 years ago Hungarian-born mathematician George Pólya found himself trapped in a loop of social awkwardness. A professor at the Swiss Federal Institute of Technology Zurich, he enjoyed ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...

In “Nothing Random,” her rousing biography of Bennett Cerf, Gayle Feldman conjures an era when a glamorous publishing figure could be a household name. By Alexandra Jacobs When you purchase an ...

Do you know what'll always save you from awkward silences at a work function? Or make you the shining star at any dinner party? A funny, interesting, and slightly niche fun fact. As it turns out, ...